15 most cited companies in REF impact case study analysis

Pharmaceutical firms were mentioned most often in universities’ impact case study submissions to the research excellence framework, according to a report

July 30, 2015
15 most cited companies in REF impact case study analysis

Click to view a high-resolution version


An analysis in The Dowling Review of Business-University Research Collaborations finds that the three most cited companies in this part of the REF were GSK, Pfizer and AstraZeneca.

In the life sciences, business interactions appear to focus on a small number of firms, as universities cited two firms in almost a quarter of submissions, says the report published on 2 July. By contrast, the two most popular companies cited as working with universities in the physical sciences and engineering accounted for 8 per cent of all collaborations in this area.

Across the four disciplinary areas of the REF, 171 companies are mentioned in more than five case studies, and 10 companies feature in case studies submitted to all panels.

Case studies submitted to the physical sciences and engineering panel had the largest total number of companies mentioned, followed by the social sciences panel, life sciences panel and arts and humanities panel.

holly.else@tesglobal.com

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

POSTSCRIPT:

Print headline: Working partnerships: The 15 most cited companies in REF impact case study analysis

Have your say

Log in or register to post comments